North-methanocarbathymidine

DB17805InvestigationalSmall molecule

North-methanocarbathymidine: Overview.

Mechanism: Pharmacologically active on Thymidine kinase
Curator reviewed
Formula / weight: C₁₂H₁₆N₂O₄ · 252.27 g/mol (avg)
Also known as: (north)-methanocarbathymidine · 1-((1s,2s,4s,5r)-4-hydroxy-5-(hydroxymethyl)bicyclo(3.1.0)hex-2-yl)-5-methyl-2,4(1h,3h)-pyrimidinedione · 2,4(1h,3h)-pyrimidinedione, 1-((1s,2s,4s,5r)-4-hydroxy-5-(hydroxymethyl)bicyclo(3.1.0)hex-2-yl)-5-methyl- · 2,4(1h,3h)-pyrimidinedione, 1-(4-hydroxy-5-(hydroxymethyl)bicyclo(3.1.0)hex-2-yl)-5-methyl-, (1s-(1.alpha.,2.alpha.,4.beta.,5.alpha.))- · N-methanocarbathymidine
Code names: N-MCT

Resolves to

Compound

Structure

InChIKeyNOWRLNPOENZFHP-ARHDFHRDSA-NSMILESCC1=CN([C@H]2C[C@H](O)[C@]3(CO)C[C@H]23)C(=O)NC1=O

Targets

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with North-methanocarbathymidine, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.